Literature DB >> 17159902

An essential function of the extreme C-terminus of MDM2 can be provided by MDMX.

Stjepan Uldrijan1, Willem-Jan Pannekoek, Karen H Vousden.   

Abstract

MDM2 (HDM2) is a ubiquitin ligase that can target the p53 tumor suppressor protein for degradation. The RING domain is essential for the E3 activity of MDM2, and we show here that the extreme C-terminal tail of MDM2 is also critical for efficient E3 activity. Loss of E3 function in MDM2 mutants deleted of the C-terminal tail correlated with a failure of these mutants to oligomerize with MDM2, or with the related protein MDMX (HDMX). However, MDM2 containing point mutations within the C-terminus that inactivated E3 function retained the ability to oligomerize with the wild-type MDM2 RING domain and MDMX, and our results indicate that oligomers containing both wild-type MDM2 and a C-terminal mutant protein retain E3 function both in auto-degradation and degradation of p53. Interestingly, the E3 activity of C-terminal point mutants of MDM2 can also be supported by interaction with wild-type MDMX, suggesting that MDMX can directly contribute to E3 function.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17159902      PMCID: PMC1782374          DOI: 10.1038/sj.emboj.7601469

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  49 in total

1.  Mutual dependence of MDM2 and MDMX in their functional inactivation of p53.

Authors:  Jijie Gu; Hidehiko Kawai; Linghu Nie; Hiroyuki Kitao; Dmitri Wiederschain; Aart G Jochemsen; John Parant; Guillermina Lozano; Zhi-Min Yuan
Journal:  J Biol Chem       Date:  2002-04-12       Impact factor: 5.157

2.  The RING domain of Mdm2 can inhibit cell proliferation.

Authors:  Jinjun Dang; Mei-Ling Kuo; Christine M Eischen; Lilia Stepanova; Charles J Sherr; Martine F Roussel
Journal:  Cancer Res       Date:  2002-02-15       Impact factor: 12.701

3.  Mdmx stabilizes p53 and Mdm2 via two distinct mechanisms.

Authors:  R Stad; N A Little; D P Xirodimas; R Frenk; A J van der Eb; D P Lane; M K Saville; A G Jochemsen
Journal:  EMBO Rep       Date:  2001-10-17       Impact factor: 8.807

4.  DNA damage induces MDMX nuclear translocation by p53-dependent and -independent mechanisms.

Authors:  Changgong Li; Lihong Chen; Jiandong Chen
Journal:  Mol Cell Biol       Date:  2002-11       Impact factor: 4.272

Review 5.  Small molecule antagonists of the MDM2 oncoprotein as anticancer agents.

Authors:  John K Buolamwini; James Addo; Shantaram Kamath; Shivaputra Patil; Darius Mason; Marian Ores
Journal:  Curr Cancer Drug Targets       Date:  2005-02       Impact factor: 3.428

6.  Hdmx recruitment into the nucleus by Hdm2 is essential for its ability to regulate p53 stability and transactivation.

Authors:  Domenico Migliorini; Davide Danovi; Emanuela Colombo; Roberta Carbone; Pier Giuseppe Pelicci; Jean-Christophe Marine
Journal:  J Biol Chem       Date:  2001-12-13       Impact factor: 5.157

Review 7.  Activation of the p53 tumor suppressor protein.

Authors:  Karen H Vousden
Journal:  Biochim Biophys Acta       Date:  2002-03-14

8.  Mdm4 (Mdmx) regulates p53-induced growth arrest and neuronal cell death during early embryonic mouse development.

Authors:  Domenico Migliorini; Eros Lazzerini Denchi; Davide Danovi; Aart Jochemsen; Manuela Capillo; Alberto Gobbi; Kristian Helin; Pier Giuseppe Pelicci; Jean-Christophe Marine
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

9.  Metal and RNA binding properties of the hdm2 RING finger domain.

Authors:  Z Lai; D A Freedman; A J Levine; G L McLendon
Journal:  Biochemistry       Date:  1998-12-01       Impact factor: 3.162

10.  mdm2 Is critical for inhibition of p53 during lymphopoiesis and the response to ionizing irradiation.

Authors:  Susan M Mendrysa; Matthew K McElwee; Jennifer Michalowski; Kathleen A O'Leary; Karen M Young; Mary Ellen Perry
Journal:  Mol Cell Biol       Date:  2003-01       Impact factor: 4.272

View more
  92 in total

1.  Regulation of p53 stability and function by the deubiquitinating enzyme USP42.

Authors:  Andreas K Hock; Arnaud M Vigneron; Stephanie Carter; Robert L Ludwig; Karen H Vousden
Journal:  EMBO J       Date:  2011-11-15       Impact factor: 11.598

2.  Mutational analysis of Mdm2 C-terminal tail suggests an evolutionarily conserved role of its length in Mdm2 activity toward p53 and indicates structural differences between Mdm2 homodimers and Mdm2/MdmX heterodimers.

Authors:  Pavlina Dolezelova; Katerina Cetkovska; Karen H Vousden; Stjepan Uldrijan
Journal:  Cell Cycle       Date:  2012-03-01       Impact factor: 4.534

3.  Regulation of MDM2 E3 ligase activity by phosphorylation after DNA damage.

Authors:  Qian Cheng; Brittany Cross; Baozong Li; Lihong Chen; Zhenyu Li; Jiandong Chen
Journal:  Mol Cell Biol       Date:  2011-10-10       Impact factor: 4.272

4.  Turning the RING domain protein MdmX into an active ubiquitin-protein ligase.

Authors:  Saravanakumar Iyappan; Hans-Peter Wollscheid; Alejandro Rojas-Fernandez; Andreas Marquardt; Hao-Cheng Tang; Rajesh K Singh; Martin Scheffner
Journal:  J Biol Chem       Date:  2010-08-12       Impact factor: 5.157

5.  Smad ubiquitylation regulatory factor 1/2 (Smurf1/2) promotes p53 degradation by stabilizing the E3 ligase MDM2.

Authors:  Jing Nie; Ping Xie; Lin Liu; Guichun Xing; Zhijie Chang; Yuxin Yin; Chunyan Tian; Fuchu He; Lingqiang Zhang
Journal:  J Biol Chem       Date:  2010-05-18       Impact factor: 5.157

6.  Structural and functional comparison of the RING domains of two p53 E3 ligases, Mdm2 and Pirh2.

Authors:  Jonathan Shloush; John E Vlassov; Ian Engson; Shili Duan; Vivian Saridakis; Sirano Dhe-Paganon; Brian Raught; Yi Sheng; Cheryl H Arrowsmith
Journal:  J Biol Chem       Date:  2010-11-17       Impact factor: 5.157

Review 7.  Making sense of ubiquitin ligases that regulate p53.

Authors:  Abhinav K Jain; Michelle Craig Barton
Journal:  Cancer Biol Ther       Date:  2010-10-01       Impact factor: 4.742

8.  A small-molecule inhibitor of MDMX activates p53 and induces apoptosis.

Authors:  Hongbo Wang; Xujun Ma; Shumei Ren; John K Buolamwini; Chunhong Yan
Journal:  Mol Cancer Ther       Date:  2010-11-12       Impact factor: 6.261

Review 9.  Targeting Mdm2 and Mdmx in cancer therapy: better living through medicinal chemistry?

Authors:  Mark Wade; Geoffrey M Wahl
Journal:  Mol Cancer Res       Date:  2009-01       Impact factor: 5.852

10.  Mdm2 and Mdm4 loss regulates distinct p53 activities.

Authors:  Juan A Barboza; Tomoo Iwakuma; Tamara Terzian; Adel K El-Naggar; Guillermina Lozano
Journal:  Mol Cancer Res       Date:  2008-06       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.